B
United Therapeutics Corporation UTHR
$307.24 $1.850.61%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Net Income -2.52% 11.15% -9.30% 41.23% -18.87%
Total Depreciation and Amortization 3.14% 2.14% 24.67% 9.49% 3.01%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -32.22% -18.55% 192.72% 30.17% -39.90%
Change in Net Operating Assets -132.31% 111.95% -373.37% 143.40% -299.35%
Cash from Operations -9.54% 62.45% -38.33% 149.83% -56.47%
Capital Expenditure -13.33% -69.62% -18.06% 51.46% -19.79%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 4.95% -10.03% -104.51% 268.33% 184.78%
Cash from Investing -7.22% -43.63% -110.88% 1,646.56% 113.43%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00% 0.00% 0.00% 0.00% --
Issuance of Common Stock -29.48% -30.33% 13.02% 531.51% -6.41%
Repurchase of Common Stock 25.00% -300.00% 99.99% -1,011,300.00% 50.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 100.00% -- --
Cash from Financing -16.54% -33.54% 95.51% -1,050.86% -1,321.05%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -27.70% 90.21% 137.90% -56.20% 147.52%
Weiss Ratings